Back
Ionis Pharmaceuticals Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
39
IONS
Ionis Pharmaceuticals
Last Price:
38.76
Seasonality Move:
10.24%
Sell
27
ALNY
Alnylam Pharmaceuticals
Last Price:
265.13
Seasonality Move:
13.19%
Sell
39
Ionis Pharmaceuticals (IONS)
is a Sell
Is Ionis Pharmaceuticals a Buy, Sell or Hold?
- The current Ionis Pharmaceuticals [IONS] share price is $38.80. The Score for IONS is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- IONS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $265.29. The Score for ALNY is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IONS Stock Price Chart
What is Ionis Pharmaceuticals's stock price today?
-
The Ionis Pharmaceuticals share price today is $38.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IONS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $265.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
IONS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.57 | Sell |
| Relative Strength Index (14 RSI): | 45.4 | Sell |
| Chaikin Money Flow: | 661402 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.02 - 39.36) | Buy |
| Bollinger Bands (100): | (39.98 - 48.52) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.76 | Sell |
| Relative Strength Index (14 RSI): | 38.35 | Sell |
| Chaikin Money Flow: | -512521 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (269.84 - 291.34) | Sell |
| Bollinger Bands (100): | (228.29 - 288.29) | Buy |
IONS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.11 | Sell |
| 20-day SMA: | 38.77 | Buy |
| 50-day SMA: | 41.43 | Sell |
| 200-day SMA: | 43.81 | Sell |
| 8-day EMA: | 38.86 | Sell |
| 20-day EMA: | 39.17 | Sell |
| 50-day EMA: | 40.9 | Sell |
| 200-day EMA: | 43.33 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 276.73 | Sell |
| 20-day SMA: | 283.15 | Sell |
| 50-day SMA: | 274.11 | Sell |
| 200-day SMA: | 206.52 | Buy |
| 8-day EMA: | 275.27 | Sell |
| 20-day EMA: | 279.04 | Sell |
| 50-day EMA: | 272.53 | Sell |
| 200-day EMA: | 227.54 | Buy |
Ionis Pharmaceuticals Earnings Growth & IONS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.29 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.48 per share, and an increase next year of $0.66 per share.
Ionis Pharmaceuticals Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||